Abstract
Drug-nutrient interactions include physicochemical, physiological, and pathophysiological events that are inherent to drug usage (Roe, 1985a). These events, which are summarized in Table I, may affect the disposition of drugs and nutrients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ames, R. P., and Peacock, P. B., 1984, Serum cholesterol during treatment of hypertension with diuretic drugs, Arch. Intern. Med. 144:710–714.
Anderson, K. E., Conney, A. H., and Kappas, A., 1982, Nutritional influences on chemical biotransformations in humans, Nutr. Report Internal. 40:161–172.
Andersson, O., 1984, The use of diuretics in modern antihypertensive therapy, Acta Pharmacol. Toxicol. 54(Suppl. 1):79–82.
Arky, R. A., Vevebrants, E. A., and Abramson, E. A., 1968, Irreversible hypoglycemia: A complication of alcohol and insulin, J.A.M.A. 206:575–578.
Barr, R. S., Wilson, H. E., and Mazzaferri, E. L., 1975, Hypomagnesemic hypocalcemia secondary to renal magnesium wasting: A possible consequence of high-dose gentamicin therapy, Ann. Intern. Med. 82:646–649.
Bartelink, A., 1974, Clinical drug interactions in the gastrointestinal tract in man, in: Clinical Effects of Interaction Between Drugs (L. E. Cluff and J. C. Petrie, eds.), Excerpta Medica, Amsterdam, p. 107.
Bauer, L. A., 1982, Interference of oral phenytoin absorption by continuous nasogastric feedings, Neurology 32:570–572.
Becker, C. E., Roe, R. L., and Scott, R. A., 1974, Alcohol as a Drug, Williams & Wilkins, Baltimore, p. 23.
Benarde, M. A., 1971, The Chemicals We Eat, McGraw-Hill, New York, pp. 89-91.
Brodie, M. J., Boobis, A. R., Hillyard, C. J., Abeyasekara, G., Stevenson, J. C., Maclntyre, I., and Kevin Park, B., 1981, Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity, Clin. Pharmacol. Therp. 30:363–367.
Brown, W. J., and Brown, W. K., 1967, Thiazide induced alteration in carbohydrate tolerance in normal men, Curr. Ther. 9:200–208.
Cacek, A. T., DeVito, J. M., and Koonce, J. R., 1986, In vitro evaluation of nasogastric administration methods for phenytoin, Am. J. Hosp. Pharm. 43:689–692.
Campbell, N. R. C., Sundaram, R. S., Werness, P. G., Van Loon, R. M., and Weinshilboum, R. ML, 1985, Sulfate and methyldopa metabolism: Metabolite patterns and platelet phenol sulfotransferase activity, Clin. Pharmacol. Ther. 37:3088–3315.
Carlson, H. B., Anthony, E. M., Russell, W. F., Jr., and Middlebrook, G., 1956, Prophylaxis of isoniazid neuropathy with pyridoxine, N. Engl. J. Med. 255:118–122.
Christopher, L. J., Ballinger, B. R., Shepherd, A. M. M., Ramsay, A., and Crooks, J., 1978, Drug prescribing patterns in the elderly: A cross-sectional study of inpatients, Age Ageing 7:74–82.
Corcino, J., Waxman, S., and Herbert, V., 1970, Mechanism of triamterene-induced megaloblastosis, Arch. Intern. Med. 73:419–424.
Crounse, R. G., 1961, Human pharmacology of griseofulvin: The effect of fat intake on gastrointestinal absorption, J. Invest. Dermatol. 37:529–533.
Cusack, B., and Denham, M. J., 1984, Nutritional status and drug disposition in the elderly, in: Drugs and Nutrition in the Geriatric Patient (D. A. Roe, ed.), Churchill Livingstone, New York, pp. 71–91.
Cusack, B., Kelly, J. G., O’Malley, K., Noel, J., Lavan, J., and Horgan, J., 1979, Digoxin in the elderly: Pharmacokinetic consequences of old age, Clin. Pharmacol. Ther. 25:772–776.
Cutie, A. J., Altman, E., and Lenkel, L., 1983, Compatibility of enterai products with commonly employed drug-drug additives, J. Parent. Ent. Nutr. 7:186–191.
D’Arcy, P. F., and Griffin, J. P., 1972, Iatrogenic Diseases, Oxford University Press, London, pp. 95–100.
Dargaville, R., 1985, Drug interactions in treatment, in: Diabetes Mellitus: A Guide to Treatment (P. Taft, ed.), Adis Health Sciences Press, Boston, Sydney, pp. 7–83.
DiLorenzo, P. A., 1967, Pellagra-like syndrome associated with isoniazid therapy, Acta Dermatol. Venereol. 47:318–322.
Doss, F. W., 1979, The effect of antipsychotic drugs on body weight; a retrospective review, J. Clin. Psychiatry 40:528–530.
Duarte, G. C., Winnaker, J. L., Becker, K. L., and Pace, A., 1971, Thiazide-induced hypercalcemia, N. Engl. J. Med. 284:828–830.
Eastwood, M. A., and Mitchell, W. D., 1976, Physical properties of fiber: A biological evaluation, in: Fiber in Human Nutrition (G. A. Spiller and R. J. Amen, eds.), Plenum Press, New York, pp. 109–129.
Favre, L., Glasson, P., and Vallotton, M. B., 1982, Reversible acute renal failure from combined triamterene and indomethacin: A study in healthy subjects, Ann. Intern. Med. 96:317–320.
Feldman, C. H., Hutchinson, V. E., Pippenger, C. E., Blumenfeld, T. A., Feldman, B. R., and Davis, W. J., 1980, Effect of dietary protein and carbohydrate on theophylline metabolism in children, Pediatrics 66:956–962.
Fichman, M. P., Vorherr, H., Kleeman, C. R., and Telfer, N., 1971, Diuretic-induced hyponatremia, Ann. Intern. Med. 75:853–863.
Greenblatt, D. J., 1979, Reduced serum albumin level in the elderly: A report from the Boston Collaborative Drug Surveillance Program, J. Am. Geriatr. Soc. 27:20–22.
Groop, L., Kosimies, S., and Tolpannen, E.-M., 1984, Characterization of patients with chlorpropamidealcohol flush, Acta Med. Scand. 215:141–149.
Hahn, T. J., and Halstead, L. R., 1979, Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration, Calcif. Tissue Int. 27:13–18.
Hansten, P. D., 1985, Drug Interactions, 5th ed., Lea & Febiger, Philadelphia, pp. 336–337.
Hathcock, J. N., 1985, Nutrient and non-nutrient effects on drug metabolism, Drug-Nutr. Interact. 4:217–234.
Hooks, M. A., Leon Longe, R., Taylor, T., and Francisco, G. E., 1986, Recovery of phenytoin from an enterai nutrient formula, Am. J. Hosp. Pharm. 43:685–688.
Hunder, G. G., Sheps, S. G., Allen, G. L., and Joyce, J. W., 1975, Daily and alternate day corticosteroid regimens in treatment of giant cell arteritis. Comparison in a prospective study, Ann. Intern. Med. 82:613–618.
Hyams, D. E., 1984a, Drug usage by the elderly, in: Drugs and Nutrition in the Geriatric Patient (D. A. Roe, ed.), Churchill Livingstone, New York, pp. 1–26.
Hyams, D. E., 1984b, Central nervous system antidepressants, in: Geriatric Pharmacology and Therapeutics (J. C. Blackwell, ed.), Science Publishers, Oxford, pp. 143–154.
Insogna, K. L., Bordley, D. R., Caro, J. F., and Lockwood, D. H., 1980, Osteomalacia and weakness from excessive antacid, J.A.M.A. 244:2544–2546.
Jamieson, M. J., 1985, Hyponatraemia, Br. Med. J. 290:1723–1728.
Kabasakalian, P., Katz, M., Rosenkrantz, B., and Townley, E., 1970, Parameters affecting absorption of griseofulvin using urinary metabolite excretion data, J. Pharm. Sci. 59:595.
Kahn, S. B., Fein, S. A., and Brodsky, L., 1968, Effects of trimethoprim on folate metabolism in man, Clin. Pharmacol. Ther. 9:550–560.
Kappas, A., Anderson, K. E., Conney, A. H., and Alvares, A. P., 1976, Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man, Clin. Pharmacol. Ther. 20:643–653.
Karim, A., Bums, T., Janky, D., and Hurwitz, A., 1985, Food-induced changes in theophylline absorption from controlled-release formulations, Part II. Importance of meal composition and dosing time relative to meal intake in assessing changes in absorption, Clin. Pharmacol. Ther. 38:642–647.
Kimelman, N., and Albert, S. G., 1984, Phenothiazine-induced hyponatremia in the elderly, Gerontology 30:132–136.
Kirkendall, W. M., and Page, E. B., 1958, Polyneuritis occurring during hydralazine therapy: Report of two cases and discussion of adverse reactions to hydralazine, J.A.M.A. 167:427–432.
Klotz, U., Avant, G. R., Hoyumpa, A., Schenker, S., and Wilkinson, G. R., 1975, The effects of age and liver disease on the disposition and elimination of diazepam in adult man, J. Clin. Invest. 55:347–359.
Krishnaswamy, K., 1985, Nutrients/non-nutrients and drug metabolism, Drug-Nutr. Meta. 4:235–247.
Lamy, P. P., 1986a, The elderly and drug interactions, J. Am. Geriatr. Soc. 34:586–592.
Lamy, P. P., 1986b, Renal effects of non-steroidal antiinflammatory drugs. Heightened risk to the elderly? J. Am. Geriatr. Soc. 34:361–367.
Larner, J., and Haynes, R. C., 1975, Insulin and oral hypoglycemie drugs: Glucagon, in: The Pharmacological Basis of Therapeutics, 5th ed. (L. S. Goodman and A. Gilman, eds.), Macmillan, New York, pp. 1521–1522.
Leikola, E., and Vartia, K. O., 1957, On penicillin levels in young and geriatric subjects, J. Qerontol. 12:48–52.
Leslie, R. D. G., Barnett, A. H., and Pyke, D. A., 1979, Chlorpropamide alochol flushing and diabetic retinopathy, Lancet 1:997–999.
Lindeman, R. D., 1986, Mineral metabolism, aging and the aged, in: Nutrition, Aging and Health (E. A. Young, ed.), Alan R. Liss, New York, pp. 187–210.
Lindenbaum, J., 1983, Drugs and vitamin B12 and folate metabolism, in: Nutrition and Drugs (M. Winick, ed.), John Wiley & Sons, New York, p. 79.
Lptz, M., Zisman, E., and Bartter, C., 1968, Evidence for a phosphorus depletion syndrome in man, N. Engl. J. Med. 278:409–415.
MacLennan, W. J., Shepherd, A. N., and Stevenson, I. H., 1984, The Elderly, Springer-Verlag, New York, pp. 8–9, 149-150.
Mars, H., 1974, Levodopa, carbidopa and pyridoxine in Parkinson’s disease. Metabolic interactions, Arch. Neurol. 30:444–447.
Mattson, R. H., Gallagher, B. B., Reynolds, E. H., and Glass, D., 1973, Folate therapy in epilepsy. A controlled study, Arch. Neurol. 29:78–81.
Mezey, E., 1978, Liver disease and nutrition, Gastroenterology 74:770–783.
Millican, C. H., 1979, Anticoagulant therapy for prevention of stroke, Med. Clin. North Am. 63:897–904.
Moser, M., 1984, Clinical trials, diuretics and the management of mild hypertension, Arch. Intern. Med. 144:789–792.
Mudge, G. H., 1975, Diuretics and other agents employed in the mobilization of edema fluid, in: The Pharmacological Basis of Therapeutics, 5th ed. (L. S. Goodman and A. Gilman, eds.), Macmillan, New York, p. 832.
Multicentre Trial Group, 1973, Controlled trial of d(—)penicillamine in severe rheumatoid arthritis, Lancet 1:275–280.
Murphy, M. B., Kohner, E., Lewis, P. J., Schumer, B., and Dollery, C. T., 1982, Glucose intolerance in hypertensive patients treated with diuretics; a 14-year follow-up, Lancet 2:1293–1295.
National Research Council, 1988, Recommended Dietary Allowances, National Academy Press, Washington, D.C.
Neuvonen, P., Matilla, M., Gothini, R., and Hackman, R., 1971, Interference of iron and milk with absorption of tetracycline, Scand. J. Clin. Lab. Invest. 27:76.
Norregaard-Hansen, K., Klitgaard, N. A., and Pedersen, K. E., 1986, The significance of the enterohepatic circulation on the metabolism of digoxin in patients with the ability of intestinal conversion of the drug, Acta Med. Scand. 220:89–92.
Overton, M., and Lukert, B., 1977, Clinical Nutrition: A Physiological Approach, Yearbook Medical Publishers, Chicago, p. 161.
Petrick, R. J., and Kleinman, N. K., 1975, Meal interference with antibiotics administered orally in hospitals, Am. J. Hosp. Pharm. 32:1008.
Platman, S. R., and Fieve, R. R., 1969, Lithium retention and excretion. The effect of sodium and fluid intake, Arch. Gen. Psychiatry 20:285–289.
Pohl, J. E. F., 1984, Hormones, in: Geriatric Pharmacology and Therapeutics (J. C. Brocklehurst, ed.), Blackwell, Oxford, London, pp. 251–268.
Prescott, L. F., Steel, R. F., and Ferner, W. R., 1970, The effects of particle size on the absorption of phenacetin in man: A correlation between plasma concentration and effects on the central nervous system, Clin. Pharmacol. Ther. 11:496.
Race, T. F., Paes, I. C., and Faloon, W. W., 1970, Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents, Am. J. Med. Sci. 259:32–41.
Ramankiewicz, J. A., and Ehrman, M., 1975, Rifampin and warfarin: A drug interaction, Ann. Intern. Med. 82:224–225.
Rapoport, M. I., and Hurd, H. F., 1964, Thiazide-induced glucose intolerance treated with potassium, Arch. Intern. Med. 113:405–408.
Reynolds, E. H., Milner, G., Mathews, D. M., and Chanarin, I., 1966, Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism, Q. J. Med. 35:521–537.
Roberts, M. A., and Caird, F. I., 1976, Steady-state kinetics of digoxin in the elderly, Age Ageing 5:214–223.
Roberts, R. S., Spitzer, W. O., Delmore, T., and Sackett, D. L., 1978, An empirical demonstration of Berkson’s bias, J. Chron. Dis. 31:119–128.
Robertson, D., 1984, Drug handling in old age, in: Geriatric Pharmacology and Therapeutics (J. C. Brocklehurst, ed.), Blackwell, Oxford, London, pp. 41–59.
Roe, D. A., 1981, Drug interference with the assessment of nutritional status, Clin. Lab. Med. 1:647–664.
Roe, D. A., 1983, Geriatric Nutrition, Prentice-Hall, Englewood Cliffs, NJ, pp. 155–156.
Roe, D. A., 1984a, Food, formula and drug effects on the disposition of nutrients, World Rev. Nutr. Diet. 43:80–94.
Roe, D. A., 1984b, Therapeutic significance of drug-nutrient interactions in the elderly, Pharmacol. Rev. 36:109S–122S.
Roe, D. A., 1984c, Drug-induced mineral depletion in the elderly, in: Drugs and Nutrition in the Geriatric Patient (D. A. Roe, ed.), Churchill Livingstone, New York, pp. 105–119.
Roe, D. A., 1985a, Drug effects on nutrient absorption, transport, and metabolism, Drug-Nutr. Interact. 4:117–135.
Roe, D. A., 1985b, Therapeutic effects of drug-nutrient interactions in the elderly, J. Am. Diet. Assoc. 85:174–181.
Roe, D. A., 1985c, Drug-Induced Nutritional Deficiencies, 2nd ed., AVI, Westport, CT, pp. 288, 315.
Roe, D. A., 1985d, Pathologial changes associated with drug-induced malnutrition, in: Nutritional Pathology: Pathobiochemistry of Dietary Imbalances (H. Sidransky, ed.), Marcel Dekker, New York, pp. 357–379.
Roe, D. A., 1987, Geriatric Nutrition, 2nd ed., Prentice Hall, Englewood Cliffs, NJ, pp. 176–200.
Rowe, J. W., Andres, R., Tobin, J. D., Norris, A. H., and Shock, N. W., 1976, The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study, J. Gerontol. 31:155–163.
Salyers, A. A., 1985, Breakdown of polysaccharides by human intestinal bacteria, in: Advances in Human Nutrition, Volume 11 (E. J. Calabrese and G. H. Scherr, eds.), Chem-Orbital, Park Forest, IL, pp. 211–231.
Sattler, F. R., Weitekamp, M. R., and Ballard, J. O., 1986, Potential for bleeding with the new beta-lactam antibiotics, Ann. Intern. Med. 105:924–931.
Seelig, M. S., 1981, Magnesium deficiency, in: The Pathogenesis of Disease: Early Roots of Cardiovascular, Skeletal and Renal Abnormalities, Plenum Medical, New York, p. 228.
Smith, T. W., 1985, New advances in the assessment and treatment of digitalis toxicity, J. Clin. Pharmacol. 25:522–528.
Solomon, G. E., Hilgartner, M. W., and Kutt, H., 1972, Coagulation defects caused by diphenylhydantoin, Neurology 22:1165–1171.
Stults, B. M., 1982, Digoxin use in the elderly, J. Am. Geriatr. Soc. 30:158–164.
Thomas, T. P. L., 1984, The complications of systemic corticosteroid therapy in the elderly, Gerontology 30:60–65.
Trier, J. S., 1962, Morphological alterations induced by methotrexate in the mucosa of human proximal intestine. 1. Serial observations by light microscopy, Gastroenterology 42:295–305.
USP, 1986, Drug Information for the Health Care Provider, 6th ed., Volume 1, U.S. Pharmacopeial Convention, Rockville, MD, pp. 285–300, 869-876.
Viswanathan, C. T., and Welling, P. G., 1984, Food effects on drug absorption in the elderly, in: Drugs and Nutrition in the Geriatric Patient (D. A. Roe, ed.), Churchill Livingstone, New York, pp. 47–70.
World Health Organization, 1981, Health care in the elderly: Report of the technical group on the use of medicaments by the elderly, Drugs 22:279–294.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Roe, D.A. (1989). Drug-Nutrient Interactions in the Elderly. In: Munro, H.N., Danford, D.E. (eds) Nutrition, Aging, and the Elderly. Human Nutrition, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2537-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2537-4_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2539-8
Online ISBN: 978-1-4899-2537-4
eBook Packages: Springer Book Archive